Industry
Latest
- Industry
UHS Q3 Margin Falls as Debt, Interest Costs Climb
Universal Health Services reported third-quarter 2026 operating income of $454 million, a 9.6% margin, down from 11.6% a year earlier, as rising long-term debt and a 46% jump in interest expense weighed on results. Revenue grew to $4.7 billion but was outpaced by higher expenses, while the company absorbed a $26 million liability reserve tied to a tentative settlement involving Cumberland Hospital for Children and Adolescents. UHS reported a $47 million favorable pre-tax impact from increased Medicaid supplemental payment programs, primarily in Washington, D.C. and California. The company also flagged that new federal Medicaid work requirements and provider fee limits, enacted in July 2025, are expected to reduce future revenue and increase uncompensated care as they phase in over coming years.
- Industry
Pediatric ICU Closures Spread as Hospitals Cite Costs, Staffing
Hospitals across the country are closing pediatric intensive care units and overnight pediatric wings, citing low patient volumes, shortages of pediatric subspecialists, and financial pressures. In the past year, PICUs closed in Montana, Oregon, and Missouri, with overnight pediatric units also shutting in Illinois and California; a broader analysis found pediatric inpatient units fell nearly 30% from 2008 to 2022, leaving three-quarters of hospitals without pediatric inpatient services. The closures force critically ill children to travel much farther for care, a problem acute in rural areas like Montana, where the nearest PICU can now be 150 miles away. Pediatricians and researchers warn that federal Medicaid cuts and new administrative eligibility hurdles, affecting coverage for the roughly half of U.S. children enrolled in Medicaid or CHIP, will accelerate these closures by reducing hospital revenue tied to enrollment.
- Industry · OK
Moody's Raises Integris Health Outlook on Risant Health Deal
Moody's affirmed Integris Health's A3 credit rating and raised its outlook from negative to positive, citing the Oklahoma City system's Oct. 21 definitive agreement to join Kaiser Permanente's Risant Health. The agency called the planned combination a "significant credit positive" that will boost Integris' value-based care capabilities and give it access to greater capital and strategic resources. Moody's also noted offsetting risks, including modest liquidity after recent capital investment, elevated leverage, and exposure to shifting government reimbursement policies. Integris, Oklahoma's largest nonprofit health system with 20 hospitals, joins Geisinger and Cone Health as Risant members; the deal is pending regulatory approval.
- Industry
Virtual COPD Care Startup Kivo Health Raises $10M Series A
Kivo Health, a Seattle-based virtual home care company treating chronic obstructive pulmonary disease, raised $10 million in Series A funding led by Allumia Ventures, bringing total financing to $16 million. The company plans to use the funds for national expansion and to eventually extend its care model to other high-cost chronic illnesses. Kivo's program combines an in-home device kit with virtual respiratory therapist sessions over nine weeks, and the company says it is covered by Medicare, Medicaid, and several major commercial health plans. Kivo says it aims to serve tens of thousands of patients within two years.
- Industry · PA
Tower Health CEO Details Turnaround Strategy After Years of Losses
Becker's Hospital Review profiles Tower Health CEO Michael Stern, who describes the three-pronged approach that returned the Pennsylvania system to positive operating income after years of losses: rebuilding culture and trust alongside financial discipline, unifying separate hospitals into one integrated system, and restructuring leadership by eliminating the COO role to push decision-making to hospital presidents. Stern also warns that reimbursement growth of roughly 1% to 1.5% annually, including Medicaid, is badly outpaced by cost increases of 5% to 15%, while rising commercial insurer denials and downgrades are consuming significant leadership time. The interview covers Tower's shift from turnaround to growth and the structural financial pressures facing health systems broadly.
- Industry
Sober Living Operators Brace for Fraud Risk, Medicaid Redetermination Churn
In a BHB+ feature, Behavioral Health Business examines how sober living facilities face thin margins, regulatory gray areas, and heightened fraud scrutiny even as demand for recovery housing grows. The piece cites a recent Department of Justice case alleging $1.6 billion in false claims against a California addiction treatment and sober living network, and notes operators increasingly link housing to clinical billing through PHPs and IOPs to stay financially viable, a practice sources warn invites fraud risk. Industry sources also describe operators having patients use sober living addresses for mail so they don't miss Medicaid eligibility communications ahead of redeterminations and other changes tied to the One Big Beautiful Bill Act taking effect in 2027. Sources warn that coverage losses will likely push more patients with substance use disorders into emergency rooms and longer hospitalizations.
- Industry
Immigration Crackdown Fuels Health Coverage Drop-Off, Analysis Finds
An analysis examines how immigration enforcement under the Trump administration, a major 2026 midterm election issue, is affecting health coverage and access. Immigration-related fear is prompting some immigrant families to avoid medical care and disenroll from coverage, even for U.S. citizen children who remain eligible. Visa restrictions also threaten a health care workforce that relies heavily on immigrant workers. Federal law has separately narrowed health coverage eligibility for lawfully present immigrants, and states have responded with varying policies to fill or widen those gaps.
- Industry · NV
Intermountain Breaks Ground on $1.2B Nevada Children's Hospital
Intermountain Health broke ground October 26 on a $1.2 billion children's hospital in Las Vegas, Nevada's first standalone pediatric facility. The roughly 828,600-square-foot hospital will sit on a 33-acre campus with an initial 180-bed inpatient tower expandable to 228 beds, offering neonatal care, pediatric and cardiac intensive care, emergency and trauma services, oncology, bone marrow transplant, and behavioral health care. The project is funded in part by a $150 million gift from Ben and Felicia Horowitz, after whom the hospital will be named, and a $50 million commitment from Larry and Heidi Canarelli. The hospital is expected to open in 2030.
- Industry
HCA Projects Flat 2027 Earnings on Medicaid Supplemental Payment Drop
HCA Healthcare CEO Sam Hazen told investors on the system's Oct. 27 third-quarter earnings call that 2027 earnings will likely be flat versus 2026, citing declining Medicaid supplemental payments and continued exchange coverage losses. The hospital system expects $550 million to $650 million less in Medicaid supplemental payment net benefits in 2027, after several states' grandfathered approvals boosted 2026 payments by $600 million to $800 million. HCA also flagged Medicaid work requirements under HR 1 as a drag on roughly 15% to 20% of its Medicaid volumes, calling the expected impact "modest" but declining to quantify it. Full 2027 guidance will come in January; uninsured patients already rose to 10.5% of equivalent admissions in Q3, up from 8.5% a year earlier, as exchange coverage losses converted "almost one for one" into uninsured volume.
- Industry
FDA Approves Pfizer's Talazoparib-Enzalutamide Combo for Prostate Cancer
The FDA approved Pfizer's talazoparib (Talzenna) in combination with enzalutamide for adults with metastatic prostate cancer carrying homologous recombination repair gene mutations, according to an Oct. 26 FDA notice. The approval relied on the TALAPRO-3 trial of 599 patients, which found median radiographic progression-free survival was not reached in the talazoparib-enzalutamide arm versus 45.8 months with placebo-enzalutamide; overall survival data remain immature. The drug carries warnings for myelodysplastic syndrome/acute myeloid leukemia, myelosuppression and embryo-fetal toxicity, and is dosed at 0.5 mg orally once daily until disease progression or unacceptable toxicity. The application received priority review.
- Industry · PA
Pennsylvania Hospital Misses Payroll Twice Amid Funding Struggles
Sharon Regional Medical Center in Pennsylvania missed payroll on Oct. 9 and again on Oct. 23, a hospital spokesperson confirmed to Becker's. CEO Peter Bastone said the hospital is working to secure funding and anticipates resolving the delay this week, acknowledging the impact on employees. The hospital closed in early 2025 under former owner Steward Health Care, which filed for Chapter 11 bankruptcy, and reopened in May 2025 under Tenor Health Foundation as Sharon Regional Health System. Tenor's leadership has cited weak Medicaid reimbursement for acute care, alongside market oversupply and prior acquisition overpayments, as structural drivers of financial distress among Pennsylvania hospitals.
- Industry · NM
UNM Health Reopens Clinics After Cyberattack Disrupted Care
UNM Health System in Albuquerque resumed regularly scheduled clinic appointments and procedures on Oct. 27 after a cybersecurity incident forced it to divert ambulances and cancel all clinic appointments the day before. The system, which operates New Mexico's only level 1 trauma center, began restoring operations in phases starting at 2:30 p.m. Oct. 26, with hospitals UNM Hospital and Sandoval Regional Medical Center remaining open throughout while IT security teams worked to resolve the incident. Nonessential staff and students at the health sciences campus were sent home during the disruption. UNM Health said it will work with patients to reschedule missed appointments and procedures.
- Industry
CMS Data Shows 4.3 Million Medicare Advantage Plans Ending in 2026
CMS data shows 4.3 million Medicare beneficiaries will lose their current plan at the end of 2026, including 3.1 million Medicare Advantage enrollees with drug coverage and 1.2 million stand-alone Part D plan enrollees. An additional 1.4 million Medicare Advantage enrollees are in plans consolidating into another plan from the same insurer. Affected beneficiaries will need to select new coverage during the annual enrollment period or risk being defaulted into a plan that may not fit their needs. This reflects continued insurer exits and plan consolidation in the Medicare Advantage market following recent payment and policy pressures.
- Industry
Hospital Systems Shift From Cost Cuts to Growth Ahead of 2027
Becker's Hospital Review reports that health system executives, including leaders at Banner Health, Trinity Health, Sutter Health and Hillsdale Hospital, say cost cutting alone can no longer sustain their finances heading into 2027. Systems like Trinity Health Mid-Atlantic and CommonSpirit are concentrating cuts in administrative, IT and revenue cycle functions rather than bedside care, while restructuring management layers and outsourcing or insourcing back-office operations. The pressure stems partly from HR 1's 2027 Medicaid work requirements and more frequent eligibility checks for expansion adults, alongside tightening federal Medicaid financing rules. Rising uninsured rates and surging bad debt and charity care, confirmed by Commonwealth Fund and Kaufman Hall data, are compressing hospital margins and pushing systems toward growth strategies alongside continued administrative cost discipline.
- Industry
Centene Cuts 12% of Workforce Amid Restructuring, Posts Q3 Loss
Centene's headcount fell 11.8% from 61,100 at the end of 2025 to 53,900 in the third quarter of 2026, driven by an enterprise optimization push and contract exits. The company's Oct. 27 earnings report shows $276 million in severance costs and $35 million in third-party vendor costs tied to the restructuring, alongside continued executive turnover at the state and corporate level. Centene posted a $71 million net loss for the quarter, a sharp improvement from a $6.6 billion loss a year earlier, and raised its 2026 earnings and revenue guidance. Medicaid membership dropped 6.4% year over year to 11.9 million, while marketplace membership fell 41.6% as the company continues to shed exchange enrollees.
- Industry · NM
UNM Health Diverts Ambulances After Cybersecurity Incident
UNM Health System in Albuquerque is diverting all ambulance traffic and canceled all clinic appointments on Oct. 26 while responding to a cybersecurity issue. The system has not disclosed the nature of the problem, whether patient data was compromised, or whether ransomware was involved. Patients were told not to come to UNM Health facilities, to call 911 for emergencies, and to delay nonemergency care. UNM Health is New Mexico's only level 1 trauma center and academic medical center, and operates the state's largest teaching hospital along with UNM Children's Hospital, UNM Sandoval Regional Medical Center, and UNM Comprehensive Cancer Center.
- Industry
Bon Secours to Buy Surgery Partners for $5.7 Billion
Bon Secours Mercy Health agreed on Oct. 26 to acquire Surgery Partners through its HealthSpan Partners affiliate in a take-private deal worth about $5.7 billion including debt, adding more than 200 ASCs, surgical hospitals and physician practices across 30 states and roughly 5,000 affiliated physicians to its 47-hospital system. The deal mirrors Ascension's $3.9 billion Amsurg acquisition and Tenet's continued expansion of United Surgical Partners International, as health systems race to build ambulatory surgery platforms amid payer pressure to shift procedures to lower-cost sites. Public shareholders will receive $23.50 per share in cash; Bain Capital affiliates will roll their roughly 39% stake into the new entity. The transaction awaits regulatory and shareholder approval and is expected to close in the first quarter of 2027, which would make Bon Secours one of the five largest ASC owners in the country.
- Industry · NC
Duke Study Ties Post-Discharge Meal Delivery to Fewer Readmissions
Duke University researchers analyzed a North Carolina hospital discharge meal pilot and found older adults who received two weeks of home-delivered meals after a hospital stay were 69 percent less likely to be readmitted within 14 days than those referred but not served, with benefits persisting at three weeks. The pilot, funded by the North Carolina General Assembly in 2021, targeted adults 60 and older at risk of food insecurity or malnutrition and was run through the state's Division of Aging and Adult Services, Meals on Wheels of North Carolina, and the NCCARE360 referral network. Duke accounted for 96 percent of statewide referrals, partly because its service area fell outside the counties covered by North Carolina's separate Medicaid-funded Healthy Opportunities Pilot, leaving clinicians with few other options to address identified food needs. The findings, published in the Journal of Hospital Medicine, raise questions about whether community meal programs and health systems have enough infrastructure to meet demand for this kind of social-needs intervention.

- Industry · NE
Fitch Upgrades Children's Nebraska Citing Medicaid Directed Payments
Fitch Ratings upgraded Omaha-based Children's Nebraska's credit rating to "AA" from "AA-" in an Oct. 21 report, citing the pediatric system's dominant market position as the only comprehensive children's hospital in its state and region. Fitch pointed to the completed Hubbard Center for Children expansion and Nebraska's approval of Medicaid state-directed payments as key supports, noting the directed payments have strengthened the system's balance sheet and helped offset rising operating costs. The system carries a stable outlook at its new rating.
- Industry
GLP-1 Pregnancy Evidence Evolves From Anecdote to ACOG Guidance
In a roundup, Becker's Hospital Review traces how evidence on GLP-1 drugs and pregnancy evolved from 2023 social media speculation about an "Ozempic baby boom" to formal clinical guidance by late 2026. Key milestones include a 2024 study finding no increased malformation risk in diabetic women taking GLP-1s around conception, an August 2026 international panel review of 34 studies finding no increased congenital anomaly risk but only partial direct evidence across clinical questions, and an October 2026 ACOG advisory recommending against use during pregnancy and stopping the drugs one to two months before conception. ACOG also said patients may resume injectable GLP-1s while breastfeeding with infant monitoring but should avoid oral versions. The guidance affects prescribers, OB-GYNs, and patients using GLP-1s for diabetes, obesity, or off-label fertility-related reasons.